Introduction
============

Chronic noncommunicable diseases (NCDs) are the greatest world public health challenge of the 21st century ([@R1],[@R2]). In 2008, approximately 36 million deaths were attributable to NCDs; most occurred in resources-limited countries, and more than half were due to diabetes and cardiovascular diseases ([@R3]). The social and economic burden of NCDs is great because they are associated with high rates of premature deaths in adults younger than 60 ([@R2],[@R4]). In response to this epidemic of NCDs, the World Health Organization (WHO) recommends population-based screening and prevention strategies. In sub-Saharan Africa, reliable data on NCDs at the population level are lacking ([@R5]), and in many countries integrated national programs that provide such data have not been implemented ([@R2]). In Senegal, previous studies of urban areas reported prevalence of 10.4% for hypertension ([@R6]), 17.9% for diabetes ([@R7]), and 31.2% for overweight and obesity ([@R2]). Staff providing primary health care services are often not equipped with skills necessary to provide care for NCDs, and the few medical specialists in Senegal are concentrated in the capital, Dakar. For private workers, annual occupational health visits are mandatory; however, health care providers often do not check patients for NCDs. If a health care provider does routinely measure blood pressure and weight, other factors such as renal function and obesity are not assessed, even in high-risk people. This study's objective was to assess the prevalence of 4 common cardiometabolic NCDs and their associated modifiable risk factors among private-sector workers in Dakar.

Methods
=======

We performed a population-based, cross-sectional study in 2 major private-sector information technology companies in Dakar. A representative sample of workers was randomly selected and screened during routine occupational health visits for high blood pressure (HBP), diabetes, obesity, and chronic kidney disease (CKD). The inclusion criteria for the study were being an employee of 1 of the 2 companies and willingness to participate. Participation in the study was free, and we obtained informed consent from each participant. We used a questionnaire to collect demographic data. Those who did not want to undertake the questionnaire were excluded from the study. We estimated socioeconomic status of participants on the basis of their educational level and total self-reported annual income. In addition to demographic data, for each participant, we measured blood pressure (BP), weight, and height; assessed physical activity level and tobacco and alcohol use; and measured fasting blood glucose (FBG), serum creatinine, and urinary albumin excretion (UAE). Skilled doctors and nurses performed all measurements. To assess tobacco and alcohol use, we asked participants if they currently smoked, had ever smoked, and if they had formerly smoked, had they stopped for a year or more. For alcohol, we asked how many drinks the person consumed in a week. Anyone consuming more than 1 drink per week was classified as a drinker. We calculated body mass index (BMI) as weight in kilograms divided by height in meters squared (kg/m^2^). Participants were identified as having hypertension, according to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure standards, if they had a BP at or higher than 140/90 mm Hg or had taken antihypertensive drugs in the previous 2 weeks ([@R8]). Participants with FBG at or higher than 1.26 g/L or who were on antidiabetic drug therapy were described as having diabetes. Participants with a BMI of 30 or higher were considered obese ([@R9]). Glomerular filtration rate (GFR) was estimated by using the Modification of Diet in Renal Disease (MDRD) equation, and UAE was measured with urine strips. CKD was defined according to National Kidney Foundation guidelines (estimated GFR \<60 mL/min or presence of albuminuria detected in 1 morning urine sample using Combur-Test (Roche diagnostics, Mannheim, Germany) ([@R10]). We assessed participants' awareness of a diagnosis of an NCD by asking if they had been told by a health professional during the previous 12 months that they had the disease or if they were undergoing a pharmacological or nonpharmacological treatment of the disease. Physical inactivity was defined as less than 30 minutes per day of moderate-intensity aerobic activity or less than 20 minutes per day of vigorous-intensity aerobic physical activity or the equivalent ([@R11]). Those with abnormal laboratory values were referred to a physician for further examination and treatment. Statistical analyses were performed with SPSS 16.0 (IBM Corporation, Chicago, Illinois). Continuous variables were presented as mean (standard deviation), and categorical variables were expressed as percentage. We used χ^2^ test and Student *t* test, as appropriate, to compare proportion and means. We used multiple regression analysis to assess the likelihood of different NCDs according to demographic and clinical data. *P* ≤ .05 was considered significant.

Results
=======

From a target population of 756 workers (502 men and 254 women), we enrolled 402 (53.2%) participants in the study, and all of them completed the screening. All participants had received some formal education, and 86.8% had completed secondary or higher education. Only 15.4% of participants were of low socioeconomic level; all others had annual incomes over the national average. Prevalence of HBP, diabetes, obesity, and CKD in the total population was 24.1%, 9.7%, 16.7%, and 22.4%, respectively ([Table 1](#T1){ref-type="table"}). Thirty-two percent of participants with hypertension, 23.0% with diabetes, 17.6% who were obese, and 89.0% with CKD were not aware of their diseases before the screening.

###### Demographic and Clinical Characteristics of Participants (N = 402), Study of Prevalence of Noncommunicable Diseases (NCDs) in Senegalese Workers, 2010[a](#T1FN1){ref-type="table-fn"}

  Characteristic                                         All Participants (N = 402)   Men (n = 266)   Women (n = 136)   *P* Value
  ------------------------------------------------------ ---------------------------- --------------- ----------------- -----------
  **Demographic**                                                                                                       
  Age, mean (SD), y                                      46.2 (7.6)                   46.9 (7.7)      44.7 (7.3)        .01
  Personal history of NCDs                               81 (20.1)                    49 (18.4)       32 (23.5)         .14
  Family history of NCDs                                 165 (41.0)                   89 (33.4)       76 (55.9)         .82
  Tobacco use                                            28 (7)                       20 (7.5)        8 (5.9)           .54
  Alcohol use                                            54 (13.5)                    48 (18.0)       6 (4.4)           .001
  Physical inactivity                                    174 (43.3)                   106 (39.8)      68 (50.0)         .05
  **Clinical**                                                                                                          
  Systolic BP, mm Hg                                     131.0 (22.0)                 131.3 (21.0)    130.5 (21.0)      .81
  Diastolic BP, mm Hg                                    82.9 (12.7)                  82.8 (13.0)     83.0 (12.2)       .71
  Hypertension stage 1[b](#T1FN2){ref-type="table-fn"}   49 (12.1)                    32 (12.0)       18 (13.2)         .72
  Hypertension stage 2[c](#T1FN3){ref-type="table-fn"}   48 (11.9)                    38 (14.3)       10 (7.3)          .70
  BMI, kg/m^2^                                           25.9 (4.3)                   25.3 (4.0)      27.1 (4.7)        .002
  \<25                                                   9 (2.2)                      8 (3.0)         1 (0.7)           .005
  ≥25 to \<30                                            323 (81.0)                   221 (55)        102 (75)          .01
  ≥30                                                    67 (16.7)                    34 (12.8)       33 (24.2)         .48
  FBG, g/L                                               1.04 (0.3)                   1.06 (0.32)     1.01 (0.96)       .11
  \<1.10                                                 319 (79.6)                   201 (75.5)      118 (86.7)        .44
  1.11 to \<1.25                                         43 (10.7)                    33 (12.8)       10 (7.3)          .29
  ≥1.26                                                  39 (9.7)                     31 (11.6)       8 (5.8)           .43
  Serum creatinine, mg/dL                                1.1 (0.3)                    0.9 (0.4)       1.0 (0.3)         .60
  eGFR, ml/min[d](#T1FN4){ref-type="table-fn"}           99.8 (23.5)                  99.6 (24.8)     97.8 (22.4)       .90
  Albuminuria \>1g/L                                     22 (5.5)                     15 (5.6)        07 (5.1)          .42
  CKD stage 1[e](#T1FN5){ref-type="table-fn"}            50 (12.4)                    34 (12.8)       16 (11.7)         .21
  CKD stage 2[f](#T1FN6){ref-type="table-fn"}            32 (8.2)                     20 (5.7)        12 (8.8)          .18
  CKD stage 3[g](#T1FN7){ref-type="table-fn"}            8 (2.0)                      5 (0.3)         3 (2.2)           .53

Abbreviations: SD, standard deviation; BP, blood pressure; BMI, body mass index; FBG, fasting blood glucose; eGFR, estimated glomerular filtration rate; CKD, chronic kidney disease.

All values are expressed as n (%), unless otherwise indicated.

BP between 140/90 mm Hg and 159/99 mm Hg.

BP ≥160/100 mm Hg.

Estimated glomerular filtration rate according to Modification of Diet in Renal Disease equation.

CKD stage 1 is an eGFR ≥90 ml/min, or the presence of albuminuria, or both.

CKD stage 2 is an eGFR 60--89 mL/min, or the presence of albuminuria, or both.

CKD stage 3 is an eGFR 30--59 mL/min, or the presence of albuminuria, or both.

More than half of participants with a diagnosed NCD had 2 diseases or more ([Table 2](#T2){ref-type="table"}). This comorbidity was most remarkable in participants with diabetes, who all had an associated NCD.

###### Distribution of Noncommunicable Diseases (NCDs) and Association of Diseases in Participants With Detected NCDs, Study of Prevalence of Chronic Cardiovascular and Metabolic Diseases in Senegalese Workers (N = 402), 2010

  NCD                             Participants with NCDs, n (%)   All participants, %
  ------------------------------- ------------------------------- ---------------------
  **Participants with 1 NCD**                                     
  Obesity                         32 (17.8)                       8.0
  CKD                             28 (15.5)                       7.0
  HBP                             28 (15.5)                       7.0
  Diabetes                        0                               0.0
  **Participants with 2 NCDs**                                    
  HBP and CKD                     40 (22.2)                       10.0
  Diabetes and obesity            18 (10.0)                       4.5
  Diabetes and CKD                5 (2.8)                         1.2
  Diabetes and HBP                5 (2.8)                         1.2
  HBP and obesity                 2 (1.1)                         0.5
  **Participants with ≥3 NCDs**                                   
  HBP and obesity and CKD         11 (6.1)                        2.7
  HBP and diabetes and CKD        7 (3.9)                         1.7
  HBP and diabetes and obesity    4 (2.2)                         1.0
  **Total**                       **180 (100)**                   **44.7**

Abbreviations: CKD, chronic kidney disease; HBP, high blood pressure.

According to univariate analyses, as age increased, so did blood pressure (odds ratio \[OR\], 2.33; *P* = .04), FBG (OR, 1.14; *P* = .05), and eGFR (OR, 0.56; *P* \< .01); physical inactivity was associated with male sex (OR, 0.67; *P* = .03). Socioeconomic status, education level, and sex were not correlated with BP, FBG, BMI, or eGFR. After multivariate regression analysis adjusting for age and sex, only SBP was correlated with an eGFR lower than 60 mL/min/1.73 m^2^ (OR, 2.1; *P* = .02), and physical inactivity was associated with a 40% increased risk for obesity (OR, 1.4; *P* = .01).

Discussion
==========

Data on the epidemiology of NCDs in sub-Saharan Africa are scarce and mainly represented by reports from South Africa. Few reports came from west Africa ([@R5],[@R12]). Our study shows high prevalence of NCDs in Senegalese private-sector workers. Hypertension was the most frequent NCD observed in our study. Reported prevalence in sub-Saharan Africa is between 6% and 48% ([@R5],[@R13],[@R14]) with a large rural-urban disparity and large increase with age ([@R12],[@R15],[@R16]). Early studies found lower prevalences, but this difference can be explained by the higher cutoff used to define HBP ([@R17]). High-income countries are still the most affected by the epidemic of NCDs, but the number of people with hypertension is expected to increase during the next few years by 80% in developing countries and by 24% in the developed world ([@R18]).

Unexpectedly, CKD (low eGFR or albuminuria) was, after HBP, the most frequent NCD in our population. Population-based studies showed lower prevalence in adults living in the Congo (12.4%) and Ghana (13.2%) ([@R19],[@R20]). These findings are alarming because low eGFR is a predictor of cardiovascular events and all-cause mortality ([@R21]), and even low-level albuminuria (1+) increases risk for cardiovascular disease by 30% ([@R22]).

Obesity in our population did not reach proportions observed in developed countries ([@R2]), but its prevalence was consistent with previously reported data in sub-Saharan African adults ([@R5],[@R13],[@R23],[@R24]). However, obesity progresses faster in developing countries, and prevalence has doubled over the last 3 decades ([@R25]). The high prevalence of obesity and overweight could be related to higher frequency of physical inactivity among Senegalese workers compared with data for workers in low-income countries (18% in men and 21% in women) ([@R2]).

Diabetes prevalence in our study group was similar to the global prevalence, which in 2008 was estimated to be 9.8% for men and 9.2% for women ([@R26]). In sub-Saharan Africa, reported prevalence from community-based studies ranges from 0% to 16.0% with marked rural-urban differences ([@R5],[@R27]). A recent screening of adults living in Dakar showed that 17.9% of participants had FBG at or higher than 1.10 g/L ([@R7]).

The high prevalence of NCDs among participants in our study contrasts with their low rate of disease awareness despite relatively high educational levels. Ignorance of disease risk is commonly found in studies addressing NCDs ([@R14],[@R28],[@R29]).

Our study has several limitations. First, we restricted our sample size to a specific profession that may not be representative of the whole Senegalese population. Second, the ranges for BMI we used in our study may not be appropriate for African populations and may need to be lowered, just as they were lowered for Asians ([@R30]). Third, measuring UAE in only 1 urine specimen could result in false-positive and false-negative results ([@R31]), and estimation of GFR in black Africans using the MDRD equation may overestimate renal function, particularly in people older than 60 years ([@R20]).

Evidence demonstrates that globalization of lifestyle and dietary habits is contributing to an epidemiological transition in middle and low-income countries ([@R2]). Concomitantly with infectious diseases, NCDs are growing rapidly while health care resources remain scarce ([@R4]). WHO recommends early detection and prevention of NCD risk factors in high-risk populations as cornerstone strategies for dealing with this new paradigm ([@R2],[@R3]). However, identification of high-risk individuals might be difficult in sub-Saharan Africa where most of the population does not consult a health care professional for preventive care because of the shortage and inaccessibility of health care resources ([@R32],[@R33]). In this context, any visit to a health care professional should be treated as an opportunity to assess individual risk for NCDs. HIV prevention and management programs in many African countries have developed strong health infrastructures and human resources that could be used for NCD programs. Compared with the majority of unemployed people in Senegal, many socio-professional groups are more able to afford regular medical check-ups because they have health coverage. Also, for private companies employing Senegalese workers, such preventive health strategies would be cost-effective inasmuch as one of the most significant socioeconomic effects of NCDs is the high financial cost of health insurance and loss of productivity ([@R4]).

Despite these limitations, our study provides a perspective on the burden of cardiovascular and metabolic diseases in a segment of the Senegalese population. Hypertension and CKD are the most frequent NCDs in this population, and awareness is low. Opportunistic screening for common preventable risk factors could improve early detection and management of NCDs in resource-limited countries like Senegal.
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